financetom
Business
financetom
/
Business
/
Oxford Industries Fiscal Q4 Adjusted Earnings Fall, Sales Rise; Issues Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Oxford Industries Fiscal Q4 Adjusted Earnings Fall, Sales Rise; Issues Guidance
Mar 28, 2024 2:36 PM

05:02 PM EDT, 03/28/2024 (MT Newswires) -- Oxford Industries ( OXM ) reported late Thursday fiscal Q4 adjusted earnings of $1.90 per share, down from $2.28 a year earlier.

Analysts polled by Capital IQ expected $1.95.

Sales for the quarter ended Feb. 3 were $404.4 million, up from $382.5 million a year earlier.

Analysts polled by Capital IQ expected $408.3 million.

The company said it expects Q1 adjusted EPS of $2.60 to $2.80. Analysts polled by Capital IQ expect $3.48. The company expects sales for the quarter of $395 million to $415 million. Analysts expect $413.9 million.

Oxford expects fiscal year 2024 adjusted EPS of $9.30 to $9.70. Analysts surveyed by Capital IQ expect $10.26.

The company expects sales for the year of $1.63 billion to $1.67 billion. Analysts polled by Capital IQ expect $1.62 billion.

The company's board raised its quarterly dividend to $0.67 per share, a 3% increase from the prior dividend payment, payable on May 3 to shareholders of record on April 19.

Price: 104.5, Change: -7.9, Percent Change: -7.03

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bicara Therapeutics Says Potential Head, Neck Cancer Drug Gets FDA Breakthrough Therapy Designation
Bicara Therapeutics Says Potential Head, Neck Cancer Drug Gets FDA Breakthrough Therapy Designation
Oct 13, 2025
08:30 AM EDT, 10/13/2025 (MT Newswires) -- Bicara Therapeutics ( BCAX ) said Monday that ficerafusp alfa in combination with pembrolizumab for the treatment of head and neck squamous cell carcinoma, or HNSCC, has received Breakthrough Therapy Designation from the US Food and Drug Administration. The designation shows recognition of human papillomavirus-negative HNSCC as a clear clinical indication within head...
Moderna Says Investigational Cancer Antigen Therapy Shows 'Promising' Early Data
Moderna Says Investigational Cancer Antigen Therapy Shows 'Promising' Early Data
Oct 13, 2025
08:30 AM EDT, 10/13/2025 (MT Newswires) -- Moderna ( MRNA ) said Monday that its investigational cancer antigen therapy, mRNA-4359, in combination with pembrolizumab, has shown promising results in its phase 1/2 trial in certain Melanoma patients. The company said the combination therapy achieved a 24% objective response rate and a 60% disease control rate. Among a subgroup of patients...
Blackboxstocks Inc. Announces its Merger Target REalloys inks LOI for a 10-Year Offtake Agreement for 15% of Tanbreez Production with Critical Metals Corp. to Strengthen North American Rare Earth Inde
Blackboxstocks Inc. Announces its Merger Target REalloys inks LOI for a 10-Year Offtake Agreement for 15% of Tanbreez Production with Critical Metals Corp. to Strengthen North American Rare Earth Inde
Oct 13, 2025
The LOI is for a 10-year off-take agreement, which plans to provide REalloys with long-term heavy rare earth feedstock from Critical Metals Corp.’s Tanbreez Project in Greenland, one of the world’s most significant deposits. REalloys’ strategic partnership aligns with U.S. and allied priorities to build a fully independent North American mine-to-magnet supply chain. NEW YORK, Oct. 13, 2025 (GLOBE NEWSWIRE)...
CleanCore Solutions Congratulates House of Doge on Successful Go-Public Transaction and Provides Treasury Update
CleanCore Solutions Congratulates House of Doge on Successful Go-Public Transaction and Provides Treasury Update
Oct 13, 2025
In collaboration with House of Doge and its strategic partners 21Shares and Robinhood, CleanCore will gain access to alpha-generating yield strategies designed to enhance treasury performance and long-term asset growth. House of Doge aims to accelerate Dogecoin’s adoption and real-world utility across commerce and paymentsHouse of Doge starts real-world tokenization initiatives, further accelerating the demand for dogecoin        ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved